
Anavex Life Sciences Faces Securities Class Action Lawsuit
Investors who purchased Anavex Life Sciences Corp. securities between November 26, 2025, and August 28, 2026, are being urged to join a newly filed class action lawsuit. The litigation targets the company and specific officers for allegedly misleading shareholders regarding internal controls and regulatory hurdles.
























